# Alzheimer’s drug study yields positive results, say makers Eisai and Biogen

- Link: https://www.widthness.com/eisai-biogen-say-alzheimers-drug-succeeds-in-slowing-cognitive-decline/
- Published: 2022-09-29T10:00:53-05:00
- Author: Curated by John Wysocki

Image caption: The logo of Eisai Co Ltd is displayed at the company headquarters in Tokyo, Japan, March 8, 2018. Image credit: Reuters / Issei Kato. Article by Deena Beasley, Julie Steenhuysen and Rocky Swift. Reuters – updated September 28, 2022. Sept 27 (Reuters) – An experimental Alzheimer’s drug made by Eisai Co Ltd (4523.T) and Biogen (BIIB.O) slowed cognitive and functional decline in a large trial of patients in the early stages of the disease, they said on Tuesday, potentially a rare win in a field littered with failed drugs. […] Click here to view original web page at www.reuters.com Curated by John Wysocki Chief Technical Officer See Full Bio